Catalyst Wire Dossier Catalyst Wire Dossier

Ganciclovir ophthalmic gel 0.15%

Ganciclovir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganciclovir ophthalmic gel 0.15%, covering 2015-11-18 to 2015-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis [NA]

See pricing